Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tolvaptan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tolvaptan 7.5mg tablets
0605020Y0AAAFAF
|
Tolvaptan | Tolvaptan | Endocrine System | 71 |
|
Tolvaptan 15mg tablets
0605020Y0AAAAAA
|
Tolvaptan | Tolvaptan | Endocrine System | 12 |
|
Tolvaptan 30mg tablets
0605020Y0AAABAB
|
Tolvaptan | Tolvaptan | Endocrine System | 9 |
|
Samsca 15mg tablets
0605020Y0BBAAAA
|
Samsca | Tolvaptan | Endocrine System | 6 |
|
Samsca 7.5mg tablets
0605020Y0BBACAF
|
Samsca | Tolvaptan | Endocrine System | 2 |
|
Jinarc 15mg tablets
0605020Y0BCAAAA
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 30mg tablets
0605020Y0BCABAB
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 45mg tablets and Jinarc 15mg tablets
0605020Y0BCACAC
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 60mg tablets and Jinarc 30mg tablets
0605020Y0BCADAD
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 90mg tablets and Jinarc 30mg tablets
0605020Y0BCAEAE
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Samsca 30mg tablets
0605020Y0BBABAB
|
Samsca | Tolvaptan | Endocrine System | No data available |
|
Tolvaptan 45mg tablets and Tolvaptan 15mg tablets
0605020Y0AAACAC
|
Tolvaptan | Tolvaptan | Endocrine System | No data available |
|
Tolvaptan 60mg tablets and Tolvaptan 30mg tablets
0605020Y0AAADAD
|
Tolvaptan | Tolvaptan | Endocrine System | No data available |
|
Tolvaptan 90mg tablets and Tolvaptan 30mg tablets
0605020Y0AAAEAE
|
Tolvaptan | Tolvaptan | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.